NARI 241220 40.00C (NARI241220C40000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

NARI241220C40000

Watchlist

15.50
+10.20+192.45%

15min DelayClose Dec 20 16:00 ET

16.40High15.50Low

Intraday

5D
Daily

News

Inari Medical(NARI.US) Director Sells US$3.34 Million in Common Stock
Moomoo NewsDec 18 18:20 ET
Truist Securities Raises Price Target on Inari Medical to $63 From $50, Keeps Hold Rating
MT NewswiresDec 18 09:33 ET · Ratings
Express News | Inari Medical Inc : Truist Securities Raises Target Price to $63 From $50
ReutersDec 18 07:31 ET
Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75
BenzingaDec 17 06:38 ET · Ratings
Inari Medical Analyst Ratings
BenzingaDec 17 06:35 ET · Ratings
Inari Medical Edges Higher Amid Takeover Speculation
Seeking AlphaDec 11 09:37 ET

Comments

Clintzilla

Nov 4 10:32

$Inari Medical (NARI.US)$ aside from that gap 38.50ish to 40 and 44 to 46ish.. i dont see why this cant go back to 70+.. they may very well leave those gaps if this market gonna rip this week

10baggerbamm

Jul 30 15:49

$Inari Medical (NARI.US)$ just another Russell 2000 stock blowing up but don't worry about buying these small caps people..

Moomoo AI

Jan 9 05:37

CEO Drew Hykes attributes Q4's robust revenue growth to healthy VTE procedure volumes, emerging therapies' traction, and strong international performance. He also highlights progress across all RCTs and the U.S. launch of LimFlow, emphasizing commitment to strong growth and operating profitability.

Press Release: Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance

Moomoo AI

Jan 8 08:11

The appointment of Rhonda Robb, with her extensive experience and proven track record, is expected to lead Okami Medical into its next phase of expansion and growth, particularly as the company prepares to commercialize its LOBO Vascular Occlusion System.

Press Release: OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

Moomoo AI

Nov 11, 2023 06:38

The increased insider selling of Inari Medical stock over buying in the last three months along with the year-long trend of insider transactions indicate caution despite high insider ownership. Company risk factors should also be considered alongside insider behavior.

Insider Spends US$3.0m Buying More Shares In Inari Medical